247 related articles for article (PubMed ID: 25642761)
1. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Falkenburg JH; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M;
Bone Marrow Transplant; 2015 Apr; 50(4):476-82. PubMed ID: 25642761
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.
Passweg JR; Baldomero H; Peters C; Gaspar HB; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Farge-Bancel D; Gennery A; Halter J; Kröger N; Lanza F; Marsh J; Mohty M; Sureda A; Velardi A; Madrigal A;
Bone Marrow Transplant; 2014 Jun; 49(6):744-50. PubMed ID: 24637898
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M
Bone Marrow Transplant; 2016 Jun; 51(6):786-92. PubMed ID: 26901709
[TBL] [Abstract][Full Text] [Related]
4. The EBMT activity survey: 1990-2010.
Passweg JR; Baldomero H; Gratwohl A; Bregni M; Cesaro S; Dreger P; de Witte T; Farge-Bancel D; Gaspar B; Marsh J; Mohty M; Peters C; Tichelli A; Velardi A; de Elvira CR; Falkenburg F; Sureda A; Madrigal A;
Bone Marrow Transplant; 2012 Jul; 47(7):906-23. PubMed ID: 22543746
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic SCT in Europe: data and trends in 2011.
Passweg JR; Baldomero H; Bregni M; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Kröger N; Farge-Bancel D; Gaspar HB; Marsh J; Mohty M; Peters C; Sureda A; Velardi A; Ruiz de Elvira C; Madrigal A;
Bone Marrow Transplant; 2013 Sep; 48(9):1161-7. PubMed ID: 23584439
[TBL] [Abstract][Full Text] [Related]
6. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
[TBL] [Abstract][Full Text] [Related]
7. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
Passweg JR; Baldomero H; Bader P; Bonini C; Duarte RF; Dufour C; Gennery A; Kröger N; Kuball J; Lanza F; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M
Bone Marrow Transplant; 2017 Jun; 52(6):811-817. PubMed ID: 28287639
[TBL] [Abstract][Full Text] [Related]
8. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Giebel S; Boumendil A; Labopin M; Seesaghur A; Baron F; Ciceri F; Esteve J; Gorin NC; Savani B; Schmid C; Wetten S; Mohty M; Nagler A
Ann Hematol; 2019 Oct; 98(10):2389-2398. PubMed ID: 31392462
[TBL] [Abstract][Full Text] [Related]
9. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.
Cairo MS; Rocha V; Gluckman E; Hale G; Wagner J
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):44-53. PubMed ID: 18162220
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
[TBL] [Abstract][Full Text] [Related]
11. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
[TBL] [Abstract][Full Text] [Related]
12. Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012.
Correa C; Gonzalez-Ramella O; Baldomero H; Basquiera AL; Baena R; Arcuri L; Puga B; Rosales C; Chávez M; Hernández C; Maldonado B; Gómez-De León A; Mendoza N; Frutos C; Aranda L; Díaz L; Hernández M; Seber A; Karduss A; Jaimovich G; Martínez-Rolon J; Bonfim C; Greinix H; Koh MBC; Aljurf M; Iida M; Saber W; Niederwieser D; Atsuta Y; Galeano S; ;
Bone Marrow Transplant; 2022 Jun; 57(6):881-888. PubMed ID: 35347244
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
[TBL] [Abstract][Full Text] [Related]
16. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
[TBL] [Abstract][Full Text] [Related]
17. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
Fitzhugh CD; Abraham A; Hsieh MM
Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
[TBL] [Abstract][Full Text] [Related]
18. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
[TBL] [Abstract][Full Text] [Related]
19. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors.
Marks DI; Woo KA; Zhong X; Appelbaum FR; Bachanova V; Barker JN; Brunstein CG; Gibson J; Kebriaei P; Lazarus HM; Olsson R; Perales MA; Pidala J; Savani B; Rocha V; Eapen M
Haematologica; 2014 Feb; 99(2):322-8. PubMed ID: 24056817
[TBL] [Abstract][Full Text] [Related]
20. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
